Clinical trials
Liposarcoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
99 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 6 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 4 |
| 2012 | 7 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 8 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 9 |
| 2025 | 9 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 48 |
| Recruiting | 18 |
| Active, not recruiting | 13 |
| Terminated | 11 |
| Withdrawn | 4 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
| Available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 13 |
| Memorial Sloan Kettering Cancer Center | 9 |
| Baylor College of Medicine | 4 |
| Dana-Farber Cancer Institute | 4 |
| Alliance for Clinical Trials in Oncology | 3 |
| M.D. Anderson Cancer Center | 3 |
| OHSU Knight Cancer Institute | 3 |
| Boehringer Ingelheim | 2 |
| Brown University | 2 |
| Children's Oncology Group | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liposarcoma | 99 |
| Sarcoma | 62 |
| Leiomyosarcoma | 44 |
| Histiocytoma, Malignant Fibrous | 31 |
| Fibrosarcoma | 26 |
| Sarcoma, Synovial | 25 |
| Hemangiosarcoma | 24 |
| Rhabdomyosarcoma | 20 |
| Neurofibrosarcoma | 17 |
| Dermatofibrosarcoma | 16 |
Trials
Showing 26 to 50 of 99. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.